What is BrainWaveBank?
BrainWaveBank, operating within the healthcare technology sector, is focused on creating advanced, at-home medical-grade platforms designed to monitor functional brain health and disorders. Their technology aims to facilitate early diagnosis and efficient patient monitoring, integrating cutting-edge analytics to provide critical data for clinical trials and research into brain disorders. This strategic financing will likely accelerate their efforts to bring novel insights and therapies to patients more rapidly.
How much funding has BrainWaveBank raised?
BrainWaveBank has raised a total of $3.6M across 3 funding rounds:
Unspecified
$1.2M
Unspecified
$1.4M
Other Financing Round
$967K
Unspecified (2017): $1.2M with participation from Invest Northern Ireland, techstart NI, Angel CoFund, and Clarendon Fund Managers
Unspecified (2020): $1.4M led by Techstart Ventures, Angel CoFund, British Business Investments, Clarendon Fund Managers, and Par Equity
Other Financing Round (2020): $967K supported by Par Equity
Key Investors in BrainWaveBank
Angel CoFund
Angel CoFund is a £100M investment fund dedicated to supporting promising UK businesses through angel and co-investment, collaborating with sector-focused angel investors to align interests and enhance the investment process.
Invest Northern Ireland
Invest Northern Ireland is a government-owned economic development agency focused on assisting businesses in Northern Ireland to access financial support and promote the region as a business destination.
Par Equity
Par Equity USA LLC operates in the Investment Banking industry, focusing on supporting businesses with investment and financial services. Their involvement suggests a strategic interest in BrainWaveBank's growth potential.
What's next for BrainWaveBank?
With substantial enterprise-level funding and a recent strategic investment, BrainWaveBank is positioned for significant scaling and further platform development. The company's focus on neurodegeneration and psychiatry, coupled with its advanced monitoring capabilities, suggests a trajectory towards becoming a key player in digital therapeutics and clinical trial support. Future growth will likely involve expanding its platform's reach, forging new partnerships within the healthcare ecosystem, and potentially exploring further rounds of financing to support global expansion and R&D initiatives.
See full BrainWaveBank company page
